Antibody-mediated Rejection Market wird durch Behandlung (Plasma Exchange, IVIG, Komplement Inhibitors, Proteasome Inhibitors), By Drugs in Development (Clazakizumab, Imlifidase), By Therapeutic Approach (Monoclonal Antibodies, Komplement Inhibitors), By Patient Type (Pre-sensitized Transplant Recipients, America, Acute Europe) Der Bericht bietet den Wert (in Mio. USD) für die oben genannten.

Antibody-mediated Rejection Market wird durch Behandlung (Plasma Exchange, IVIG, Komplement Inhibitors, Proteasome Inhibitors), By Drugs in Developmen....